Trial intelligence / Profile preview

Visualisation of coronary arteries in adult-onset growth hormone deficiency

2006-001574-24Phase 4Completed

Sponsor
Radboud University Medical Center
Start
Jun 2006
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, single-arm trial of somatropin in growth hormone deficiency (GHD) and coronary arteriosclerosis, sponsored by Radboud University Medical Center. Primary endpoint: Presence of atherosclerotic disease in the coronary system. Started Jun 2006; status: completed.

02

Drugs

somatropin
03

Conditions

growth hormone deficiency (GHD)coronary arteriosclerosis

Beyond the preview

Go deeper on 2006-001574-24.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-001574-24.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call